Trial intelligence / Profile preview

Riluzole in Fragile X Syndrome

NCT00895752Phase 4Completed

Sponsor
Indiana University
Start
Apr 2009
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of riluzole in Fragile X syndrome (FXS), sponsored by Indiana University. Started Apr 2009; status: completed.

02

Drugs

riluzole
03

Conditions

Fragile X syndrome (FXS)

Beyond the preview

Go deeper on NCT00895752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00895752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call